Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

Neuroscience

Volumn 272, Issue , 2014, Pages 116-130

  Islam, M R ^a   Moriguchi, S ^a   Tagashira, H ^a   Fukunaga, K ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Depression; Neurogenesis; Rivastigmine; Serotonin 1A receptor

Indexed keywords

KETANSERIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PROTEIN KINASE B; RIVASTIGMINE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; CARBAMIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; DRUG EFFECTS; LONG TERM POTENTIATION; METABOLISM; OLFACTORY BULB; PHYSIOLOGY; SURGERY;

ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICE; NEUROGENESIS; OLFACTORY BULB; PHENYLCARBAMATES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 84900868858     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.04.046     Document Type: Article

References (87)

1. Abdel-Aal R.A., Assi A.A., Kostandy B.B. Rivastigmine reverses aluminium-induced behavioral changes in rats. Eur J Pharmacol 2011, 659:169-176.
2. Albertino M.A., Vogels O.J., Van Domburg P.H., Ten Donkellar H.J. Cell loss in the nucleus raphe dorsalis in Alzheimer's disease. Neurobiol Aging 1992, 13:461-468.
3. Benninghoff J., Gritti A., Rizzi M., Lamorte G., Schloessen R.J., Schmitt A. Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells. Neuropsychopharmacology 2010, 35:893-903.
4. Bhagwagar Z., Hinz R., Taylor M., Fancy S., Cowen P., Grasby P. Increased 5-HT (2A) receptor binding in euthymic medication-free patients recovered from depression: a positron emission study with [(11) C] MDL 100, 907. Am J Psychiatry 2006, 163:1580-1587.
5. Brezun J.M., Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neurosci 1999, 89:999-1002.
6. Brezun J.M., Daszuta A. Serotonergic reinnervation reverses lesion-induced decreases in PSA-NCAM labeling and proliferation of hippocampal cells in the adult rats. Hippocampus 2000, 10:37-46.
7. Buritova J., Berrichon G., Cathala C., Colpaert F., Cussac D. Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative Elisa study. Neuropharmacology 2009, 56:350-361.
8. Chang B., Daniele C.A., Gallagher K., Madonia M., Mitchum R.D., Barrett L. Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol 2011, 106:801-808.
9. Chen C.P., Eastwood S.L., Hope T., McDonald B., Francis P.T., Esiri M.M. Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioral changes. Neuropathol Appl Neurobiol 2000, 26:347-355.
10. Chen J., Shen C., Meller E. 5-HT1A receptor-meidated regulation of mitogen activated protein kinase phosphorylation in rat brain. Eur J Pharm 2002, 452:155-162.
11. Chen B.H., Yan B.C., Park J.H., Ahn J.H., Lee D.H., Lee Y.L., et al. Ariprazole, an atypical antipsychotic drug, improves maturation and complexity of neuroblast dendrites in the mouse dentate gyrus via increasing superoxide dismutases. Neurochem Res 2013, 38:1980-1988.
12. Chung K.K., Martinez M., Herbert J. C-fos expression, behavioural, endocrine and autonomic responses to acute social stress in male rats after chronic restraint: modulation by serotonin. Neuroscience 2000, 95:453-463.
13. Cooper-Kuhn C.M., Winkler J., Kuhn H.G. Decreased neurogenesis after cholinergic forebrain lesion in the adult rat. J Neurosci Res 2004, 77:155-165.
14. Couillard-Despres S., Winner B., Schaubeck S., Aigner R., Vroemen M., Aigner L., et al. Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci 2005, 21:1-14.
15. Cowen D.S., Johnson-Farley N.N., Travkina T. 5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons. J Neurochem 2005, 93:910-917.
16. Dagyté G., Den Boer J.A., Trentani A. The cholinergic system and depression. Behav Brain Res 2011, 221:574-582.
17. David D.J., Wang J., Samuels B.A., Rainer Q., David I., Hen R., et al. Implications of the functional integration of adult-born hippocampal neurons in anxiety-depression disorders. The Neuroscientist 2010, 16:578-591.
18. Davies P., Maloney A.F.J. Selective loss of cerebral cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
19. Diaz S.L., Doly S., Narboux-Nême N., Fernández S., Mazot P., Banas S.M., et al. 5-HT2B receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry 2012, 17:154-163.
20. Durpret D., Fabre A., Döbrössy M.D., Panatier A., Rodriguez J.J., Lamarque S. Spatial learning depends on both the addition and removal of new hippocampal neurons. PLoS Biol 2007, 5:1683-1694.
21. Ferŕes-Coy A., Pilar-Cuellar F., Vidal R., Paz V., Masana M., Cortés R., et al. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Transl Psychiatry 2013, 3:e211.
22. 1A receptor-mediated pathways by repeated lithium treatments in rats. Can J Physion Pharmacol 2000, 78:392-399.
23. Furukawa-Hibi Y., Alkam T., Nitta A., Matsuyama A., Mizoquchi H., Yamada K., et al. Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice. Behav Brain Res 2011, 225:222-229.
24. Galindo-Charles L., Hernandez-Lopez S., Galarraga E., Tapia D., Bargas J., et al. Serotonergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholine receptors in rats. Synapse 2008, 62:601-615.
25. Garduno J., Galindo-Charles L., Jimenez-Rodriquez J., Galarrage E., Tapia D., Mihailescu S., et al. Presynaptic alpha4beta2 nicotinic acetylcholine receptors increase glutamate release and serotonin neuron excitability in the dorsal raphe nucleus. J Neurosci 2012, 32:15148-15157.
26. Guilloux J.P., David D.J.P., Xia L., Nguyen H.T., Rainer Q., Guiard B.P., et al. Characterization of 5-HT(1A/1B) -/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology 2011, 61:478-488.
27. Han F., Shioda N., Moriguchi S., Yamamoto Y., Raie A.Y., Fukunaga K., et al. Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus. J Pharmacol Exp Ther 2008, 326:127-134.
28. Han F., Nakano T., Yamamoto Y., Shioda N., Lu Y.M., Fukunaga K. Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice. Brain Res 2009, 265:205-214.
29. Harkin A., Kelly J.P., Leonard B.E. A review of the relevance and validity of olfactory bulbectomy as a model of depression. Clin Neurosci Res 2003, 3:253-262.
30. Haubrich D.R., Reid W.D. Effects of pilocarpine or arecoline administration on acetylcholine levels and serotonin turnover in rat brain. J Pharmacol Exp Ther 1972, 181:19-27.
31. Hellweg R., Zueger M., Fink K., Hörtnagl H., Gass P. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol Dis 2007, 25:1-7.
32. Héry F., Bourquoin S., Hamon M., Ternaux J.P., Glowinski J. Control of the release of newly synthesized 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices. Nauryn Schmiedeberqs Arch Pharmacol 1977, 296:91-97.
33. Hozumi S., Nakagawasai O., Tan-No K., Niijima F., Murata A., Tadano T., et al. Characteristics of changes in cholinergic function and impairment of learning-memory related behavior induced by olfactory bulbectomy. Behav Brain Res 2003, 138:9-15.
34. Huang G.J., Herbert J. The role of 5-HT1A receptors in the proliferation and survival of progenitor cells in the dentate gyrus of the adult hippocampus and their regulation by corticoids. Neuroscience 2005, 135:803-813.
35. Jaako-Movits K., Zharkovsky T., Pedersen M., Zharkovsky A. Decreased hippocampal neurogenesis following olfactory bulbectomy is reversed by repeated citalopram administration. Cell Mol Neurobiol 2006, 26:1559-1570.
36. 2A/2C receptor blockade regulates progenitor cell proliferation in the adult rat hippocampus. Neurosci let 2008, 441:210-214.
37. Kaneko N., Okano H., Sawamoto K. Role of cholinergic system in regulating survival of newborn neurons in the adult mouse dentate gyrus and olfactory bulb. Genes Cells 2006, 11:1145-1159.
38. Kelly J.P., Wrynn A.S., Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 1997, 74:299-316.
39. Kempermann G., Kuhn G., Gage F.H. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997, 386:493-495.
40. Klemenhagen K.C., Gordan J.A., David D.J., Hen R., Gross C.T. Increased fear responses to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology 2006, 31:101-111.
41. Klempin F., Babu H., De Pietri Tonelli D., Alarcon E., Kempermann G., et al. Oppositional effects of serotonin receptors 5-HT1a, 2 and 2c in the regulation of adult hippocampal neurogenesis. Front Mol Neurosci 2010, 3:1-11.
42. Kokaia Z., Thored P., Arvidsson A., Lindvall O. Regulation of stroke-induced neurogenesis in adult brain-recent scientific progress. Cereb Cortex 2006, 1:162-167.
43. Kornum B.R., Weikop P., Moller A., Ronn L.C., Krudsen G.M., Aznar S. Serotonin depletion results in a decrease of the neuronal activation caused by rivastigmine in the rat hippocampus. Brain Research 2006, 1073-1074:262-268.
44. 2B receptor. Mol Pharmacol 1994, 46:227-234.
45. 1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease. Psychopharmacology (Berl) 2011, 213:431-439.
46. Lüttgen M., Ove Oqren S., Meister B. Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus. Brain Res 2004, 1010:156-165.
47. Machado D.G., Cunha M.P., Neis V.B., Balen G.O., Colla A., Grando J., et al. Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy. Pharmacol Biochem Behav 2012, 103:220-229.
48. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
49. McDermott C.L., Gray S.L. Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression. Ann Pharmacother 2012, 46:599-605.
50. Mclean J.H., Shipley M.T. Serotonergic afferents to the rat olfactory bulb: II. Changes in fiber distribution during development. J Neurosci 1987, 7:3029-3039.
51. Mcllwain K.L., Merriweather M.Y., Yuva-Paylor L.A., Paylor R. The use of behavioral test batteries: effects of training history. Physiol Behav 2001, 73:705-717.
52. Mohapel P., Leanza G., Kokaia M., Lindvall O. Forebrain acetylcholine regulate adult hippocampal neurogenesis and learning. Neurobiol Aging 2005, 26:939-946.
53. Moore R.Y., Halaris A.E. Hippocampal innervations by serotonin neurons of the mid brain raphe in the rat. J Comp Neurol 1975, 164:171-183.
54. Moriguchi S., Han F., Nakagawasai O., Tadano T., Fukunaga K. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice. J Neurochem 2006, 97:22-29.
55. Moriguchi S., Shinoda Y., Yamamoto Y., Sasaki Y., Miyajima K., Fukunaga K., et al. Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice. PLoS One 2013, 8:e60863.
56. Moriguchi S., Tagashira H., Sasaki Y., Yeh J.Z., Sakagami H., Fukunaga K., et al. CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment. J Neurochem 2013, 10.1111/jnc.12510.
57. Mowla A., Mosavinasab M., Haghshenas H., Borhani Haghighi A. Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol 2007, 27:484-487.
58. Naik R.S., Hartmann J., Kiewert C., Duysen E.G., Lockridge O., Klein J. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. J Pharm Pharm Sci 2009, 12:79-85.
59. Nakajima A., Yamakuni T., Haraquechi M., Omae N., Song S.Y., Ohizumi A citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. J Pharmacol Sci 2007, 105:122-126.
60. Nakamura S., Tani Y., Maeeno Y., Ishihara T., Ohno T. Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems. Pharmacol Biochem Behav 1992, 42:119-130.
61. Nesterova I.V., Gurevich E.V., Nesterova V.I., Otmakhova N.A., Bobkova N.V. Bulbectomy-induced loss of raphe neurons is counteracted by antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:127-140.
62. Polter A.M., Li X. 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal 2010, 22:1406-1412.
63. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
64. Praag V.H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nature Neurosci 1999, 2:266-270.
65. 1A receptor antagonist administration decreases cell proliferation in the dentate gyrase. Brain Res 2002, 955:264-267.
66. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Hen R., et al. Requirement of hippocampal neurogenesis or the behavioral effects of antidepressants. Science 2003, 301:805-809.
67. Shioda N., Yamamoto Y., Han F., Moriguchi S., Yamaguchi Y., Fukunaga K., et al. A novel cognitive enhancer, ASET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice. J Pharmacol Exp Ther 2010, 333:43-50.
68. Shioda N., Yamamoto Y., Han F., Fukunaga K. Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior. Yakugaku Zasshi 2011, 131:505-511.
69. Skelin I., Sato H., Diksic M. Acute challenge with d-fenfluramine decreases regional cerebral glucose utilization in sham, but not in OBX, rats: an autoradiographic study. Brain Res 2010, 1310:162-171.
70. Song C., Leonard B.E. The olfactory bulbectomized rat as a model of depression. Neurosci Biobehav Rev 2005, 29:627-647.
71. Spalletta G., Gianni W., Giubilei F., Casini A.R., Sancesario G., Caltaqirone C., Cravello L. Rivastigmine patch ameliorates depression in mild AD: preliminary evidence from a 6-month open-label observational study. Alzheimer Dis Assoc Disord. 2013, 27(3):289-291.
72. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
73. Synder J.S., Choe J.S., Clifford M.A., Jeurling S.I., Hurley P., Cameron, et al. Adult-born hippocampal neurons are more numerous, faster maturing and more involved in behavior in rats than in mice. J Neurosci 2009, 29:14484-14495.
74. Tanti A., Belzung C. Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?. Neuroscience 2013, 252:234-252.
75. Teegarden S. Behavioral phenotyping in rats and mice. Mater Methods 2012, 2:122. http://dx.doi.org/10.13070/mm.en.2.122.
76. Uchiumi O., Kasahara Y., Fukui A., Hall F.S., Uhl G.R., Sora I. Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine. Neuropharmacology 2013, 64:348-356.
77. Vanderwolf C.H. Cerebral activity and behavior: control by central cholinergic and serotonergic systems. Int Rev Neurobiol 1988, 30:225-340.
78. Wang J.W., David D.J., Monckton J.E., Battaglia F., Hen R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult born hippocampal granule cells. J Neurosci 2008, 28:1374-1384.
79. Wang S.H., Zhang Z.J., Guo Y.J., Sui Y.X., Sun Y. Involvement of serotonin neurotransmission in hippocampal neurogenesis and behavioral responses in a rat model of post-stroke depression. Pharmacol Biochem Behav 2010, 95:129-137.
80. Watanabe A., Hasegawa S., Nishi K., Nguyen K.Q., Diksic M. Chronic buspirone treatment normalized regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study. Brain Res Bull 2006, 69:101-108.
81. Weisstaub N.V., Zhou M., Lira A., Lambe E., González-Maeso J., Ginqrich J.A. Cortical 5-HT2A receptor modulates anxiety-related behaviors in mice. Science 2006, 313:536-540.
82. Wilkinson D.G., Francis P.T., Schwam E., Payne-Parrish J. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 2004, 21:453-478.
83. 1B receptors disruption in mice. Neurosci Lett 2012, 521:20-25.
84. Xu Y., Ku B.S., Yao H.Y., Lin H.Y., Ma X., Li X.J., et al. Antidepressants effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 2005, 82:200-206.
85. Yamamoto Y., Fukunaga K. Donepezil rescues the medial septum cholinergic neurons via nicotinic ACh receptor stimulation in olfactory bulbectomised mice. Adv Alzheimer Dis 2013, 2:161-170.
86. Yamamoto Y., Shioda N., Han F., Moriguchi S., Yamaguchi Y., Fukunaga K., et al. Novel cognitive enhancer ST101 enhances acetylcholine release in mouse dorsal hippocampus through T-type voltage-gated calcium channel stimulation. J Pharmacol Sci 2013, 121:212-226.
87. Zeni A.L., Zomkowski A.D., Maraschin M., Rodriques A.L., Tasca C.I. Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: Evidence for the involvement of the serotonergic system. Eur J Pharmacol 2012, 679:68-74.